Active surveillance of HCV is rarely
performed due to resource constraints and unreliable serological
tests, the lack of molecular (PCR) based tests,9 and no available
HCV-specific antiviral therapy.10 Since reliable HCV tests are not
available for widespread screening in low-resource settings,
physicians must often rely on clinical intuition. Unfortunately,
data on symptoms and objective signs of chronic HCV infection in